Diazoxide-mediated insulin suppression in obese men: A dose-response study

Diabetes, Obesity and Metabolism

Volumn 7, Issue 3, 2005, Pages 239-245

  Schreuder, T ^a   Karreman, M ^a   Rennings, A ^a   Ruinemans Koerts, J ^a   Jansen, M ^a   de Boer, Hans ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Diazoxide; Hyperglycaemia; Hyperinsulinism; Insulin suppression; Obesity

Indexed keywords

DIAZOXIDE; GLUCOSE; INSULIN; PLACEBO;

ADULT; ANKLE EDEMA; ARTICLE; BODY WEIGHT; BODY WEIGHT DISORDER; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; EYELID EDEMA; GLUCOSE BLOOD LEVEL; HAND DISEASE; HEART PALPITATION; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESPONSE; MALE; MEAL; METABOLIC PARAMETERS; OBESITY; OPEN STUDY; PERIPHERAL EDEMA; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; STANDARDIZATION; STATISTICAL SIGNIFICANCE; WEIGHT GAIN;

EID: 17444365833     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00449.x     Document Type: Article

References (11)

1. Polonsky KS, Given BD, van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 1988; 81: 442-448.
2. Campfield LA, Smith FJ, Mackie G et al. Insulin normalization as an approach to the pharmacological treatment of obesity. Obes Res 1995; 3 (Suppl. 4): 591S-603S.
3. Alemzadeh R, Jacobs W, Pitukcheewanont P. Antiobesity effect of diazoxide in obese Zucker rats. Metabolism 1996; 45: 334-341.
4. Alemzadeh R, Langley G, Upchurch L et al. Beneficial effect of diazoxide in obese hyperinsulinemic adults. J Clin Endocrinol Metab 1998; 83: 1911-1915.
5. Howard BV. The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action. J Clin Endocrinol Metab 1984; 58: 544-548.
6. Goode PN, Farndon JR, Anderson J et al. Diazoxide in the management of patients with insulinoma. World J Surg 1986; 10: 586-592.
7. Gill GV, Rauf O, MacFarlane IA. Diazoxide treatment for insulinoma: a national UK survey. Postgrad Med J 1997; 73: 640-642.
8. Touati G, Poggi-Travert F, de Baulny HO et al. Long-term treatment of persistent hyperinsulinaemic hypoglycemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr 1998; 157: 628-633.
9. Knoben JE, Anderson PO. Diazoxide. In: Handbook of Clinical Drug Data, 7th edn. Hamilton, IL: Hamilton Press, 1993; 549-551.
10. Hardman JG, Limbird LE. Diazoxide. In: Goodman and Gillman's: the Pharmaceutical Basis of Therapeutics, l0th edn. New York, NY: McGraw Hill, 2001; 890-891.
11. Ratzmann KP, Ruhnke R, Kohnert KD. Effect of pharmacological suppression of insulin secretion on tissue sensitivity to insulin in subjects with moderate obesity. Int J Obes 1983; 7: 453-458.